Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis

BACKGROUND: Nadroparin is used during hemodialysis to prevent clotting of the extra corporeal system. During nocturnal hemodialysis patients receive an increased dosage of nadroparin compared to conventional hemodialysis. We tested whether the prescribed dosage regimen of nadroparin, according to Du...

詳細記述

保存先:
書誌詳細
出版年:BBA Clin
主要な著者: Buitenwerf, Edward, Risselada, Arne J., van Roon, Eric N., Veeger, Nic J.G.M., Hemmelder, Marc H.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2015
主題:
Regular Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4661578/
https://ncbi.nlm.nih.gov/pubmed/26672512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbacli.2015.03.006
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料